The role of insulin in modulating phosphoinositide breakdown and accumulation of inositol phosphates was investigated in isolated rat pancreatic islets by using GPAIS (guinea-pig anti-insulin antiserum> that neutralizes effects of insulin in the medium. At either 3.0 mm-or 16.7 mM-glucose or 3.0 mM-glucose plus I0 uM-arecaidine propargyl ester (muscarinic receptor agonist), GPAIS 
INTRODUCTION
It is widely recognized that hydrolysis of the membrane lipid PtdInsP2 leads to the generation of the two intracellular messengers InsP3 and diacylglycerol (Berridge & Irvine, 1984; Downes & Michell, 1985) . Thelatter stimulates the phospholipiddependent protein kinase C, whereas the InsP3 produced, by mobilizing Ca2+ from intracellular stores, leads to activation of calmodulin and other Ca2+-sensitive proteins, which has been extensively reviewed (Berridge, 1984; Farese, 1983) . Glucose may also stimulate insulin secretion of rat pancreatic islets by activating these two branches of the Ca2+-messenger system (Freinkel et al., 1975; Laychock, 1983; Best et al., 1987; Zawalich et al., 1987) . During a batch incubation of a large number of islets in a small volume, a high insulin concentration in the medium can be expected (Verspohl et al., 1979) ; however, attention has not been paid to the possibility that this endogenously released insulin may have counter-regulatory effects on inositol turnover, thus obscuring glucose effects. This topic is interesting, since (first) insulin inhibits various glucose effects in islets and (second) insulin exhibits a negative feedback on insulin secretion (Verspohl et al., 1979; Frerichs et al., 1965) , the mechanism of which is not completely understood. By using GPAIS (guinea-pig anti-insulin antiserum), we aimed in this study to determine whether the released insulin might affect phosphoinositide breakdown and accumulation of inositol phosphates in isolated rat pancreatic islets. GPAIS has been proved an useful tool to increase the glucose effect on insulin release (Verspohl et al., 1979) (Mutschler & Hultzsch, 1973) ; this cholinergic agonist is selective for muscarinic receptors by not interacting with nicotinic receptors, and was shown to stimulate insulin release (Verspohl et al., 1990 ).
Isolation of rat pancreatic islets
This was done as described by Lacy & Kostianovsky (1967) , with slight modifications as described by Verspohl & Ammon (1980 Abbreviations used: InsP3, myo-inositol trisphosphate (both isomers with positional determinants of the phosphate groups at either 1,4,5 or 1,3,4); GPAIS, guinea-pig anti-insulin antiserum; APE, arecaidine propargyl ester; KRH, Krebs-Ringer Hepes (118.4 mM-NaCl, 4.84 mM-KCl, 1.19 mM-KH2PO4, 1.19 mM-MgSO ,7H20, lOmM-Hepes).
myo-inositol, but no radioactive material. Batches of 100 islets were then incubated in 0.4 ml of KRH buffer in the presence of unlabelled myo-inositol (1 mM) for 15 min to enable them to recover from the labelling and washing procedure. The islets were washed again once, and were thereafter incubated together with various concentrations of either test substance such as glucose or APE in the presence of either GPAIS or control serum (preimmunization serum) as indicated in the legends to give a final volume of 200 ,l. These experiments were performed in the presence of 10 mM-LiCl. The incubations were terminated after 180 s by adding 200 ,ul of ice-cold 9 % (w/v) HCI04. The islets were sonicated (Econoclean; Spirig, Rappersvil, Switzerland) for 30 s (35 Hz, 150W) and centrifuged (lOOOOg for 15 min) to precipitate proteins. The supernatant was extracted with 2 x 420,u1 of methanol/chloroform/ 12 M-HCI (200:100:1, by vol.). To the combined extraction fluids was added 400,l of chloroform and 200 ,ul of water. Aqueous products containing inositol phosphates plus myo-inositol were separated from lipophilic products containing PtdIns and its phosphates by centrifugation (10000 g for 15 min); the lower organic phase containing the inositol phospholipids was dried under N2.
Measurement of the water-soluble inositol phosphates released by hydrolysis of the phosphoinositides
The pH of the supernatants was adjusted to pH 8 by addition of a mixture of KOH (3 M) and sodium tetraborate (54 mM).
Labelled InsP, InsP2 and InsP3 were separated from each other and from [3H]inositol by anion-exchange chromatography on 1 ml Dowex AG-X8 columns (formate form; 2 cm x 0.5 cm columns; 100-200 mesh) (Downes & Michell, 1981; Berridge et al., 1983; Batty et al., 1985) . All fractions that were carefully monitored for their elution profile by using appropriate radioactively labelled internal standards were later combined, and portions were mixed with 15 ml of Aquasol Universal LSC Cocktail (NEN, Boston, MA, U.S.A.), and counted for radioactivity by liquid-scintillation spectrometry (Packard Isocap/300). Total labelled inositol phosphates were expressed as a percentage of total [3H]inositol lipids passed through the column.
Total amount of Ins(1,4,5)P, The absolute concentration of Ins(1,4,5)P3, which is the biologically relevant isomer, was measured by using a radioreceptor assay. In this, after a preincubation time 100 islets were incubated with the test compounds in 200 ,ul for 180 s. The supernatant was then centrifuged at 12000 g for 15 min at 4°C and the final supernatant was freeze-dried; after addition of 100 #1 of assay buffer, the samples were added to the Ins(1,4,5)P3 assay mixture, containing a high specific radioactivity of labelled Ins(1,4,5)P3 together with a specific Ins(1,4,5)P3-binding protein.
Separation of inositol-containing phospholipids
The dried lower organic phase also containing precipitated proteins was reconstituted in 100 lO of chloroform/methanol (9: 1, v/v), and after 20 ,ul had been used for the determination of total amount of phosphoinositides the remaining 80,ul was applied to precoated silica-gel 60 t.l.c. plates. Standard solutions of Ptdlns, PtdlnsP and PtdInsP2 were also applied, and the plate were developed as described by Schacht (1978) . The plates were autoradiographed by using EN3HANCE (NEN), and afterwards radioactivity of cut plates corresponding to authentic phospholipids was counted.
Preparation of GPAIS
The procedure for this was that described by Verspohl et al. (1979) ; 1 ,ul of GPAIS was able to bind 201 + 8 ,uunits of insulin. For control experiments, preimmunization serum of guinea pigs was used. Because serum contains many different factors, i.e. various serum proteins, hormones (including insulin), proteases etc., precipitation with (NH4)2SO4 was performed before freeze-drying. When GPAIS was added in experiments, an equivalent amount of fatty-acid-free BSA was omitted from the main incubation medium (total concentration of BSA and/or GPAIS was 0.50)
Statistics
For statistical evaluation, multiple comparisons of means were carried out by two-way analysis of variance (F-ratio test) and subsequent Student's t test.
RESULTS
In Table 1 the effects of GPAIS, guinea-pig control serum and PtdInsP2 formation in general, it is hard to say whether polyphosphoinositide hydrolysis is the source of additional radioactivity incorporated into InsP3, which is the breakdown product of PtdInsP2.
In Table 2 the data on specific measurements of Ins(1,4,5)P3 are summarized when GPAIS, guinea-pig control serum or BSA buffer was used. The data show that GPAIS significantly increases Ins(1,4,5)P3 in islets compared with control serum, independently of the stimulator (glucose or APE) used. The maximal insulinotropic concentrations are 16.7 mm for glucose and 10 /M for APE (Verspohl et al., 1990 (Best & Malaisse, 1984; Best et al., 1987; Zawalich et al., 1987) and the inhibition of InsP3 accumulation by simultaneously released insulin, as shown in the present study.
This fits very well with the observation that a substance such as carbachol is more potent than glucose in increasing InsP3 accumulation (Best et al., 1987) , since it is less insulinotropic than glucose (Hermans et al., 1986) . This may be interpreted by the fact that the modulatory effect of insulin in the medium on turnover of polyphosphoinositides is assumed to be less prominent. Interestingly, Zawalich et al. (1987) have shown that cholecystokinin increases InsP3, but mostly at low glucose concentrations, when again insulin in the medium is low. It is reasonable to assume that the hitherto measured and published effects of highly insulinotropic substances such as glucose on InsP3 accumulation are small (1.5-4 times above basal) (Best & Malaisse, 1984; Best et al., 1987; Zawalich et al., 1987) and are more or less underestimated, owing to the presence of released insulin. In contrast, in other target tissues initiators are much more effective (e.g. carbachol 7-fold in rat parotid glands; (Berridge et al., 1983) . Our study also contributes to the possible mechanism of negative feedback of insulin on insulin secretion (Ammon & Verspohl, 1976; Verspohl et al., 1979) , since other possibilities, such as decrease in cyclic AMP and inhibition of 45Ca2+ uptake, all have proved negative (E. J. Verspohl, unpublished work) .
In conclusion, the data obtained by using GPAIS show (first) that insulin increases phosphoinositide turnover, which is most obvious for InsP3 accumulation, (second) that this effect is independent of the stimulator used (glucose or APE), and (third) that InsP3 accumulation may have been underestimated in former investigations when high insulin concentrations owing to stimulators are present in the incubation medium. The observed decrease in inositol phosphate accumulation may be involved in the yet-undefined mechanism of various insulin effects on islets, e.g. inhibition of insulin release.
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